Literature DB >> 32683751

Nardilysin controls cardiac sympathetic innervation patterning through regulation of p75 neurotrophin receptor.

Mikiko Ohno1,2, Kiyoto Nishi2, Yoshinori Hiraoka3, Shinichiro Niizuma4, Shintaro Matsuda2, Hirotaka Iwasaki1, Takeshi Kimura2, Eiichiro Nishi1.   

Abstract

Cardiac sympathetic innervation is critically involved in the regulation of circulatory dynamics. However, the molecular mechanism for the innervation patterning has remained elusive. Here, we demonstrate that nardilysin (NRDC, Nrdc), an enhancer of ectodomain shedding, regulates cardiac sympathetic innervation. Nardilysin-deficient (Nrdc-/- ) mice show hypoplastic hearts, hypotension, bradycardia, and abnormal sympathetic innervation patterning. While the innervation of left ventricle (LV) of wild-type mice is denser in the subepicardium than in the subendocardium, Nrdc-/- LV lacks such a polarity and is uniformly and more abundantly innervated. At the molecular level, the full-length form of p75 neurotrophin receptor (p75NTR , Ngfr) is increased in Nrdc-/- LV due to the reduced ectodomain shedding of p75NTR . Importantly, the reduction of p75NTR rescued the abnormal innervation phenotype of Nrdc-/- mice. Moreover, sympathetic neuron-specific, but not cardiomyocyte-specific deletion of Nrdc recapitulated the abnormal innervation patterning of Nrdc-/- mice. In conclusion, neuronal nardilysin critically regulates cardiac sympathetic innervation and circulatory dynamics via modulation of p75NTR .
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  Heart; ectodomain shedding; nardilysin; p75NTR; sympathetic nerve

Year:  2020        PMID: 32683751     DOI: 10.1096/fj.202000604R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  1 in total

1.  Nardilysin in adipocytes regulates UCP1 expression and body temperature homeostasis.

Authors:  Sayaka Saijo; Mikiko Ohno; Hirotaka Iwasaki; Shintaro Matsuda; Kiyoto Nishi; Yoshinori Hiraoka; Natsuki Ide; Takeshi Kimura; Eiichiro Nishi
Journal:  Sci Rep       Date:  2022-03-02       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.